M. Moberg

发表

A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations

J. Vestbo, P. Alonso-Coello, A. Mathioudakis, 2019, ERJ Open Research.

Prognostic Value of C-Reactive Protein, Leukocytes, and Vitamin D in Severe Chronic Obstructive Pulmonary Disease

J. Vestbo, P. Lange, T. Ringbaek, 2014, TheScientificWorldJournal.

Association Between Vitamin D Status and COPD Phenotypes

J. Vestbo, T. Ringbaek, M. Moberg, 2014, Lung.

Vitamin D deficiency and airflow limitation in the Baltimore Longitudinal Study of Ageing

L. Ferrucci, E. Wouters, M. Spruit, 2015, European journal of clinical investigation.

Acute effects of physical activity patterns on plasma cortisol and brain-derived neurotrophic factor in relation to corticospinal excitability

O. Tarassova, V. Blom, M. Ekblom, 2022, Behavioural Brain Research.

Validation of the i-BODE Index as a Predictor of hospitalization and Mortality in Patients with COPD Participating in Pulmonary Rehabilitation

J. Vestbo, Johanna E A Williams, P. Lange, 2014, COPD.

Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials

T. Biering-Sørensen, J. Vestbo, J. Leuppi, 2021, Respiratory Research.

A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations – The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol

J. Vestbo, N. Seersholm, J. Jensen, 2017, BMC Pulmonary Medicine.

Targeted AntiBiotics for Chronic pulmonary diseases (TARGET ABC): can targeted antibiotic therapy improve the prognosis of Pseudomonas aeruginosa-infected patients with chronic pulmonary obstructive disease, non-cystic fibrosis bronchiectasis, and asthma? A multicenter, randomized, controlled, open-

N. Seersholm, C. Ulrik, F. Rosenvinge, 2022, Trials.

Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial.

J. Vestbo, N. Seersholm, J. Jensen, 2019, The Lancet. Respiratory medicine.

Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial

T. Biering-Sørensen, C. Porsbjerg, J. Lundgren, 2020, Trials.

Elevated blood eosinophils in acute COPD exacerbations: better short- and long-term prognosis

C. Porsbjerg, J. Vestbo, T. Jess, 2020, European clinical respiratory journal.

Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials

J. Vestbo, P. Alonso-Coello, A. Mathioudakis, 2019, ERJ Open Research.

Systemic antibiotics for Pseudomonas aeruginosa infection in outpatients with non-hospitalised exacerbations of pre-existing lung diseases: a randomised clinical trial

N. Seersholm, T. Klausen, P. Sivapalan, 2024, Respiratory research.

Inhaled corticosteroids and Stenotrophomonas maltophilia in outpatients with chronic obstructive pulmonary disease: a retrospective cohort study

P. Sivapalan, J. Eklöf, J. Boel, 2024, BMJ open respiratory research.